- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Myomo Inc (MYO)
The Myomo share price today is 1.630, view NYSE MYO stock exchange data. Track the latest Myomo share price with real-time updates on MYO stock performance including market cap, day range, 52-week range and dividend yield. Access MYO charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.610
1.700
52 wk Range
0.605
1.885
MYO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.6101.700
52 wk Range
0.6051.885
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MYO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
4.640
Upside
+184.66%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Form 144 MYOMO For: 13 July- Investing.com
Myomo CMO Harry Kovelman sells $30,329 in stock- Investing.com
Form 4 Myomo Inc For: 13 July- Investing.com
Myomo chief medical officer sells $29,895 in shares- Investing.com
- Myomo CMO Harry Kovelman sells $30,329 in stock
- Investing.com
- Myomo chief medical officer sells $29,895 in shares
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 4.640
(+184.66% Upside)
Myomo Inc Earnings Call Summary for Q2/2026
- Myomo Q2 revenue rose 21% YoY to $11.7M, beating estimates of $10.29M; net loss narrowed to $0.09/share vs. consensus of $0.10/share loss.
- Gross margin expanded sharply to 72.1% from 62.7% YoY; adjusted EBITDA loss improved to $800K from $4M, signaling progress toward profitability.
- Company raised full-year 2026 revenue guidance to $45M-$47M from prior $43M-$46M range; Q3 revenue expected at $11.5M-$12M.
- Record 255 MyoPro unit orders placed in Q2, up 23% YoY; recurring patient referrals now represent 53% of revenue vs. 26% a year earlier.
- Cash burn reduced to $1.9M from $8.9M YoY; management expects second-half 2026 cash burn below $2M as revenue growth outpaces expense increases.
Last Updated: 06-08-2026, 02:56 am
Read Full TranscriptEarnings
Latest Release
05-08-2026
EPS / Forecast
-0.09 / -0.10
Revenue / Forecast
11.7M / 10.29M
Compare MYO to Peers and Sector
Metrics to compare | MYO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMYOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.5x | −0.8x | −0.3x | |
PEG Ratio | 0.09 | −0.09 | 0.00 | |
Price/Book | 11.1x | 2.1x | 2.6x | |
Price / LTM Sales | 1.5x | 2.3x | 3.0x | |
Upside (Analyst Target) | 184.7% | 127.4% | 58.6% | |
Fair Value Upside | Unlock | 10.5% | 8.4% | Unlock |
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran’s administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Myomo (MYO) Share Price Today?
The Myomo share price today is 1.630.
What is the current Myomo (MYO) share price and day range?
As of 03-10-2026, the Myomo share price is 1.630, with a previous close of 1.630. The share price has ranged from 1.610 to 1.700 today, while the 52-week range spans from 0.605 to 1.885.
What Is the Myomo Market Cap?
As of today, Myomo market cap is 63.770M.
What Is the Myomo (MYO) Share Price Target?
The average 12-month share price target for Myomo is 4.640, with a high estimate of 10.5 and a low estimate of 1.7. 5 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +184.66% Upside potential.
What Is Myomo's Earnings Per Share (TTM)?
The Myomo EPS (TTM) is -0.367.
When Is the Next Myomo Earnings Date?
Myomo will release its next earnings report on 11-11-2026.
From a Technical Analysis Perspective, Is MYO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Myomo Trade On?
Myomo is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Myomo?
The stock symbol for Myomo is "MYO."
How Many Times Has Myomo Stock Split?
Myomo has split 1 times.
How Many Employees Does Myomo Have?
Myomo has 195 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.